ScholarLens Back to search
2007•Applied Journal of General PracticeRequires access

Curative Efficacy of Ambrocol for Lower Respiratory Tract Infection in Children

Le Wang

Open publisher page 0 citations

Abstract

Objective To assess safety and efficacy of Ambrocol oral liquid on lower respiratory tract infection symptom,such as cough,expectoration,gasp,polypnea,cyanosis,wheezing and wet rale,in children.Methods 126 children with lower respiratory tract infection (aged from 3 months to 8 years old) were randomly assigned to treatment group (with Ambrocol based on routine measure)and control group (with routine measure only).Results There was significant difference in clinical symptom improvement between the two groups.Conclusions Ambrocol was safe and effective for the lower respiratory tract infection in children.

About this research paper

What this paper is about

Objective To assess safety and efficacy of Ambrocol oral liquid on lower respiratory tract infection symptom,such as cough,expectoration,gasp,polypnea,cyanosis,wheezing and wet rale,in children.Methods 126 children with lower respiratory tract infection (aged from 3 months to 8 years old) were randomly assigned to treatment group (with Ambrocol based on routine measure)and control group (with routine measure only).Results There was significant difference in clinical symptom improvement between the two groups.Conclusions Ambrocol was safe and effective for the lower respiratory tract infection in children.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess safety and efficacy of Ambrocol oral liquid on lower respiratory tract infection symptom,such as cough,expectoration,gasp,polypnea,cyanosis,wheezing and wet rale,in children.Methods 126 children with lower respiratory tract infection (aged from 3 months to 8 years old) were randomly assigned to treatment group (with Ambrocol based on routine measure)and control group (with routine measure only).Results There was significant difference in clinical symptom improvement between the two groups.Conclusions Ambrocol was safe and effective for the lower respiratory tract infection in children.

Key concepts: Medicine, Respiratory tract, Respiratory tract infections, Respiratory system, Upper respiratory tract infection, Significant difference, Respiratory infection, Lower respiratory tract infection

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Curative Efficacy of Ambrocol for Lower Respiratory Tract Infection in Children — Research Paper | ScholarLens